The phase 2b/3 clinical trial (NCT05683496) evaluated izokibep versus placebo in non-infectious, non-anterior uveitis.

III-21,” a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer ...

Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

The Managing Director of Merit Healthcare Limited, Dr Lolu Ojo, spoke to FAITH AJAYI about his career as a pharmacist and ...

It’s safe to say that stock investors are closing out 2024 in a rather upbeat mood. The markets posted substantial gains, ...